Hancock Whitney’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $656K | Sell |
1,250
-514
| -29% | -$270K | 0.01% | 503 |
|
|
2025
Q1 | $1.12M | Sell |
1,764
-5,650
| -76% | -$3.58M | 0.04% | 293 |
|
|
2024
Q4 | $5.28M | Sell |
7,414
-355
| -5% | -$253K | 0.17% | 99 |
|
|
2024
Q3 | $8.17M | Sell |
7,769
-36
| -0.5% | -$37.8K | 0.26% | 83 |
|
|
2024
Q2 | $8.2M | Sell |
7,805
-74
| -0.9% | -$77.8K | 0.28% | 80 |
|
|
2024
Q1 | $7.58M | Buy |
7,879
+278
| +4% | +$268K | 0.26% | 90 |
|
|
2023
Q4 | $6.68M | Sell |
7,601
-54
| -0.7% | -$47.4K | 0.25% | 89 |
|
|
2023
Q3 | $6.3M | Buy |
7,655
+134
| +2% | +$110K | 0.26% | 87 |
|
|
2023
Q2 | $5.4M | Sell |
7,521
-716
| -9% | -$514K | 0.21% | 99 |
|
|
2023
Q1 | $6.77M | Sell |
8,237
-709
| -8% | -$583K | 0.27% | 86 |
|
|
2022
Q4 | $6.45M | Buy |
8,946
+200
| +2% | +$144K | 0.25% | 89 |
|
|
2022
Q3 | $6.03M | Buy |
+8,746
| New | +$6.03M | 0.26% | 84 |
|
|
2021
Q1 | – | Sell |
-1,424
| Closed | -$688K | – | 813 |
|
|
2020
Q4 | $688K | Sell |
1,424
-58
| -4% | -$28K | 0.02% | 451 |
|
|
2020
Q3 | $830K | Sell |
1,482
-4
| -0.3% | -$2.24K | 0.03% | 403 |
|
|
2020
Q2 | $927K | Sell |
1,486
-10,755
| -88% | -$6.71M | 0.04% | 383 |
|
|
2020
Q1 | $5.98M | Sell |
12,241
-4,113
| -25% | -$2.01M | 0.23% | 114 |
|
|
2019
Q4 | $6.14M | Sell |
16,354
-10,020
| -38% | -$3.76M | 0.2% | 139 |
|
|
2019
Q3 | $7.32M | Sell |
26,374
-1,330
| -5% | -$369K | 0.24% | 115 |
|
|
2019
Q2 | $8.67M | Sell |
27,704
-571
| -2% | -$179K | 0.28% | 103 |
|
|
2019
Q1 | $11.6M | Buy |
28,275
+6,851
| +32% | +$2.81M | 0.37% | 73 |
|
|
2018
Q4 | $8M | Sell |
21,424
-9,360
| -30% | -$3.5M | 0.27% | 106 |
|
|
2018
Q3 | $12.4M | Buy |
+30,784
| New | +$12.4M | 0.35% | 84 |
|